• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾病综合征患者的脂质和载脂蛋白水平

Lipid and apolipoprotein levels in patients with nephrotic syndrome.

作者信息

Ohta T, Matsuda I

出版信息

Clin Chim Acta. 1981 Dec 9;117(2):133-43. doi: 10.1016/0009-8981(81)90034-6.

DOI:10.1016/0009-8981(81)90034-6
PMID:6796292
Abstract

Plasma lipids and 6 plasma apolipoproteins (apoA-I, apoA-II, apoB, apoC-I, apoC-II and apoC-III) were studied in 23 patients with nephrotic syndrome. The elevated total cholesterol, triglyceride and apoB levels in nephrotic patients decreased gradually, after the disappearance of proteinuria. During the acute stage high density lipoprotein cholesterol, as well as the sum of apoA-I and apoA-II were similar in the patients and the controls. ApoA-I and apoA-II were transiently elevated during the recovery stage. All three apoC proteins (apoC-I, apoC-II and apoC-III) were elevated during the acute stage. A significant decrease in apoC-I, apoC-II and apoC-III was observed during the first 3 weeks after normalization of the urine protein. The ratio of apoC-II/apoC-III was reduced during the first 4 weeks after normalization of urine protein and then returned to the control level. The results suggest that as far as total levels are concerned, changes of apoC-II, apoC-III and the ratio of apoC-II/apoC-III appear to have no effect on the development of hyperlipidemia in th nephrotic syndrome.

摘要

对23例肾病综合征患者的血浆脂质和6种血浆载脂蛋白(载脂蛋白A-I、载脂蛋白A-II、载脂蛋白B、载脂蛋白C-I、载脂蛋白C-II和载脂蛋白C-III)进行了研究。肾病患者总胆固醇、甘油三酯和载脂蛋白B水平升高,蛋白尿消失后逐渐下降。急性期患者的高密度脂蛋白胆固醇以及载脂蛋白A-I和载脂蛋白A-II的总和与对照组相似。载脂蛋白A-I和载脂蛋白A-II在恢复期短暂升高。急性期所有三种载脂蛋白C(载脂蛋白C-I、载脂蛋白C-II和载脂蛋白C-III)均升高。尿蛋白正常化后的前3周,载脂蛋白C-I、载脂蛋白C-II和载脂蛋白C-III显著下降。尿蛋白正常化后的前4周,载脂蛋白C-II/载脂蛋白C-III的比值降低,然后恢复到对照水平。结果表明,就总水平而言,载脂蛋白C-II、载脂蛋白C-III以及载脂蛋白C-II/载脂蛋白C-III的比值变化似乎对肾病综合征高脂血症的发生没有影响。

相似文献

1
Lipid and apolipoprotein levels in patients with nephrotic syndrome.肾病综合征患者的脂质和载脂蛋白水平
Clin Chim Acta. 1981 Dec 9;117(2):133-43. doi: 10.1016/0009-8981(81)90034-6.
2
Evaluation of serum lipid abnormalities in chronic nephritis.慢性肾炎患者血清脂质异常的评估
Kidney Int Suppl. 1999 Jul;71:S147-9. doi: 10.1046/j.1523-1755.1999.07137.x.
3
Human intestinal lipoproteins. Studies in chyluric subjects.人肠道脂蛋白。乳糜尿患者的研究。
J Clin Invest. 1979 Jul;64(1):233-42. doi: 10.1172/JCI109444.
4
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.尿毒症性脂蛋白异常血症的脂质和载脂蛋白谱——与肾功能及透析的关系
Nephron. 1991;57(4):401-10. doi: 10.1159/000186303.
5
The compositional abnormalities of lipoproteins in diabetic renal failure.糖尿病肾衰竭患者脂蛋白的组成异常
Nephrol Dial Transplant. 1998 Nov;13(11):2833-41. doi: 10.1093/ndt/13.11.2833.
6
Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.吉非贝齐对慢性肾功能不全患者脂蛋白异常的影响:一项人类慢性肾病对照研究
Nephron. 1997;75(3):286-94. doi: 10.1159/000189551.
7
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.具有自发性慢性进行性肾病综合征的近交系大鼠中的血脂蛋白异常血症。
J Lipid Res. 1991 Oct;32(10):1675-87.
8
Lipid and apolipoprotein compositions of two species of ApoA-I containing lipoproteins in young girls with insulin-dependent diabetes mellitus.
Pediatr Res. 1990 Jul;28(1):42-5. doi: 10.1203/00006450-199007000-00010.
9
Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.血浆载脂蛋白对脂蛋白脂肪酶介导的小、大脂质乳剂脂解作用的影响。
Biochim Biophys Acta. 2003 Jun 10;1632(1-3):31-9. doi: 10.1016/s1388-1981(03)00058-1.
10
Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.人载脂蛋白 A-II 通过调节脂蛋白脂肪酶活性和高密度脂蛋白蛋白质组来决定血浆甘油三酯。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):232-8. doi: 10.1161/ATVBAHA.109.198226. Epub 2009 Nov 12.

引用本文的文献

1
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.肾病综合征中的血脂异常:机制与治疗
Nat Rev Nephrol. 2018 Jan;14(1):57-70. doi: 10.1038/nrneph.2017.155. Epub 2017 Nov 27.
2
The lipid story in chronic kidney disease: a long story with a happy end?慢性肾脏病中的脂质故事:一个有美好结局的漫长故事?
Int Urol Nephrol. 2013 Oct;45(5):1273-87. doi: 10.1007/s11255-012-0296-8.
3
Follow up study on children with dyslipidaemia detected by mass screening at 18 months of age: effect of 12 months dietary treatment.对18个月大时通过大规模筛查发现的血脂异常儿童的随访研究:12个月饮食治疗的效果
Eur J Pediatr. 1993 Nov;152(11):939-43. doi: 10.1007/BF01957537.
4
Hyperlipidemia in childhood nephrotic syndrome.儿童肾病综合征中的高脂血症
Pediatr Nephrol. 1993 Oct;7(5):559-66. doi: 10.1007/BF00852550.
5
Lipoprotein profiles at different stages of the nephrotic syndrome.肾病综合征不同阶段的脂蛋白谱。
Eur J Pediatr. 1988 Apr;147(3):233-8. doi: 10.1007/BF00442685.
6
Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.尿白蛋白排泄增加的1型(胰岛素依赖型)糖尿病患者血浆脂蛋白和纤维蛋白原浓度异常。
Diabetologia. 1988 Mar;31(3):142-5. doi: 10.1007/BF00276846.
7
[Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].[肾脏疾病中脂质代谢紊乱的病理生理学与治疗]
Klin Wochenschr. 1991 Aug 1;69(11):455-62. doi: 10.1007/BF01649416.
8
Management of nephrotic syndrome in childhood.儿童肾病综合征的管理
Drugs. 1991 Jul;42(1):30-51. doi: 10.2165/00003495-199142010-00003.